Delivery Order SPE2DX15D2213-SPE2DX24F8A5E
Award Date
4/24/24
Potential Completion Date
4/25/24
Potential Value
$5.7K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,911.01 fixed-price contract is for the supply of Glipizide ER 10 mg tablets, a medication used to treat diabetes. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,856.38 firm-fixed-price delivery order is for the supply of GLIPIZIDE ER 10 MG TABLET 1000S, a generic diabetes medication. The contract has an ultimate completion date of June 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,759.59, is for the delivery of 4,565,177,703 units of the medication Glipizide ER 10 mg tablet. The contract has an ultimate completion date of July 18, 2024 and is a firm fixed-price type contract. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite...
This federal contract award, valued at $3,675.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, to provide GLIPIZIDE ER 10 MG TABLET 1000S to support military healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of 4,564,804,911 tablets of Glipizide ER 10 mg, a medication used to treat type 2 diabetes. The $2,641.54 firm fixed price delivery order was issued under Amerisourcebergen's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of GLIPIZIDE ER 10 MG TABLET 500S. The $4,912.99 firm fixed-price delivery order has a completion date of November 12, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,826.38 firm fixed-price delivery order is for the supply of GLIPIZIDE ER 10 MG TABLET 500S, a medication used to treat diabetes. The contract has an ultimate completion date of May 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Glipizide ER 10 mg tablets. The contract has a total ceiling value of $4,261.23 and an ultimate completion date of May 6, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,103.28, is a Firm Fixed Price Delivery Order for the supply of GLIPIZIDE ER 10 MG TABLET 500S. The contract has an ultimate completion date of January 23, 2025. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not designated as a set-aside contract. The company...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $8,281.71 and a completion date of July 1, 2024. It is a firm fixed-price contract for the delivery of 4565029632 GLIPIZIDE ER 10 MG TABLET 500S, a generic pharmaceutical product. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) that...